Japan Keytruda NSCLC Approval Sets Stage For Opdivo Showdown

Keytruda has been approved in Japan for lung cancer, including first-line use, in a batch of new regulatory clearances that also include the country's first prescription drug for irritable bowel syndrome with constipation.